| Primary |
| Breast Cancer |
62.4% |
| Hypertension |
7.5% |
| Breast Cancer Female |
6.0% |
| Depression |
2.8% |
| Malignant Melanoma Stage Iv |
2.4% |
| Anticoagulant Therapy |
2.2% |
| Osteoporosis |
2.2% |
| Diabetes Mellitus |
2.0% |
| Insomnia |
1.6% |
| Prophylaxis |
1.4% |
| Constipation |
1.3% |
| Metastases To Bone |
1.1% |
| Osteopenia |
1.1% |
| Chronic Obstructive Pulmonary Disease |
1.0% |
| Hypercholesterolaemia |
1.0% |
| Malignant Melanoma |
1.0% |
| Neoplasm Malignant |
1.0% |
| Breast Cancer In Situ |
0.8% |
| Breast Cancer Stage Iii |
0.7% |
| Breast Neoplasm |
0.7% |
|
| Pulmonary Embolism |
8.2% |
| Cataract |
7.7% |
| Cerebral Infarction |
7.2% |
| Uterine Polyp |
6.7% |
| Weight Increased |
6.7% |
| Hepatic Steatosis |
6.2% |
| Thrombosis |
6.2% |
| Uterine Cancer |
6.2% |
| Transient Ischaemic Attack |
5.1% |
| Myalgia |
4.6% |
| Intracranial Venous Sinus Thrombosis |
4.1% |
| Organising Pneumonia |
4.1% |
| Uterine Leiomyoma |
4.1% |
| Cryptogenic Organising Pneumonia |
3.6% |
| Endometrial Hyperplasia |
3.6% |
| Vaginal Haemorrhage |
3.6% |
| Vomiting |
3.6% |
| Disease Progression |
3.1% |
| Visual Disturbance |
3.1% |
| Cerebral Haemorrhage |
2.6% |
|
| Secondary |
| Breast Cancer |
69.3% |
| Breast Cancer Metastatic |
5.3% |
| Hypertension |
3.3% |
| Prostate Cancer |
2.6% |
| Breast Cancer Female |
2.3% |
| Depression |
2.0% |
| Menopause |
1.7% |
| Drug Use For Unknown Indication |
1.6% |
| Arthritis |
1.4% |
| Product Used For Unknown Indication |
1.3% |
| Bipolar Disorder |
1.0% |
| Breast Cancer Recurrent |
1.0% |
| Epilepsy |
1.0% |
| Hypercholesterolaemia |
1.0% |
| Hypothyroidism |
1.0% |
| Bone Pain |
0.9% |
| Colitis |
0.9% |
| Headache |
0.9% |
| Seasonal Allergy |
0.9% |
| Breast Neoplasm |
0.7% |
|
| Weight Increased |
10.6% |
| Uterine Polyp |
9.6% |
| Interstitial Lung Disease |
7.7% |
| Myocardial Infarction |
5.8% |
| Vena Cava Injury |
5.8% |
| Cataract |
4.8% |
| Endometrial Cancer |
4.8% |
| Headache |
4.8% |
| Osteoarthritis |
4.8% |
| Osteoporosis |
4.8% |
| Endometrial Disorder |
3.8% |
| Endometrial Hyperplasia |
3.8% |
| Hepatic Steatosis |
3.8% |
| Radiation Skin Injury |
3.8% |
| Rash |
3.8% |
| Thrombocytopenia |
3.8% |
| Uterine Cancer |
3.8% |
| Vomiting |
3.8% |
| Acute Myeloid Leukaemia |
2.9% |
| Cervix Carcinoma |
2.9% |
|
| Concomitant |
| Breast Cancer |
32.9% |
| Metastases To Bone |
19.2% |
| Breast Cancer Metastatic |
5.9% |
| Osteoporosis |
4.7% |
| Pain |
4.3% |
| Anxiety |
3.4% |
| Drug Use For Unknown Indication |
3.1% |
| Menopause |
3.0% |
| Gastrooesophageal Reflux Disease |
2.9% |
| Hormone Replacement Therapy |
2.8% |
| Postoperative Care |
2.6% |
| Hypertension |
2.5% |
| Product Used For Unknown Indication |
2.0% |
| Chemotherapy |
1.8% |
| Breast Cancer Female |
1.6% |
| Fibromyalgia |
1.6% |
| Autoimmune Thyroiditis |
1.5% |
| Constipation |
1.5% |
| Osteitis Deformans |
1.5% |
| Prophylaxis |
1.5% |
|
| Tooth Extraction |
12.1% |
| Weight Decreased |
10.9% |
| Weight Increased |
8.6% |
| Disease Progression |
6.3% |
| Varicose Vein |
5.7% |
| Toothache |
5.2% |
| Wound Debridement |
5.2% |
| Wound Drainage |
5.2% |
| Pyrexia |
4.6% |
| Interstitial Lung Disease |
4.0% |
| Wound Dehiscence |
4.0% |
| Pain |
3.4% |
| Thrombotic Thrombocytopenic Purpura |
3.4% |
| Tooth Abscess |
3.4% |
| Tumour Marker Increased |
3.4% |
| Urinary Tract Infection |
3.4% |
| Hypertension |
2.9% |
| Osteomyelitis |
2.9% |
| Vaginal Disorder |
2.9% |
| Acute Myeloid Leukaemia |
2.3% |
|
